# TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

> **NCT05507879** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 200 (estimated)

## Conditions studied

- Breast Carcinoma
- Cardiomyopathy
- Congestive Heart Failure

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Medical Record

## Key facts

- **NCT ID:** NCT05507879
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05507879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05507879, "TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05507879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*